miR34a in pcDNA3.1 Citations (3)
Originally described in: Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients.Eichelser C, Stuckrath I, Muller V, Milde-Langosch K, Wikman H, Pantel K, Schwarzenbach H Oncotarget. 2014 Oct 30;5(20):9650-63. PubMed Journal
Articles Citing miR34a in pcDNA3.1
| Articles |
|---|
Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA.
Richardson CD, Ray GJ, DeWitt MA, Curie GL, Corn JE.
Nat Biotechnol. 2016 Jan 20. doi: 10.1038/nbt.3481.
PubMed
Associated Plasmids |
| RNA structural analysis of the MYC mRNA reveals conserved motifs that affect gene expression. O'Leary CA, Andrews RJ, Tompkins VS, Chen JL, Childs-Disney JL, Disney MD, Moss WN. PLoS One. 2019 Jun 17;14(6):e0213758. doi: 10.1371/journal.pone.0213758. eCollection 2019. PubMed |
| Apoptosis-targeted gene therapy for non-small cell lung cancer using chitosan-poly-lactic-co-glycolic acid -based nano-delivery system and CASP8 and miRs 29A-B1 and 34A. Chattopadhyay S, Sarkar SS, Saproo S, Yadav S, Antil D, Das B, Naidu S. Front Bioeng Biotechnol. 2023 Jun 6;11:1188652. doi: 10.3389/fbioe.2023.1188652. eCollection 2023. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.